Innate Pharma IPHA Q1 2026 Earnings Deep EPS Miss Weighs on Shares as Pipeline Progress Remains in Focus JOE Q1 2026 Earnings EPS of 024 as Stock Edges Lower Fortune Brands Innovations FBIN Q1 2026 Earnings EPS Falls Just Short of Estimates Despite Strong Stock Reaction PAG Q1 2026 Earnings EPS Beats Estimates by 352 Amid Stable Operations GEOS Q1 2026 Earnings WiderThanExpected Loss and Revenue Disruption Pressure Shares CISS Q3 2025 Earnings Negative EPS and Significant Stock Decline